[go: up one dir, main page]

NO20052655D0 - Sammensmeltede heterocykliske forbindelser - Google Patents

Sammensmeltede heterocykliske forbindelser

Info

Publication number
NO20052655D0
NO20052655D0 NO20052655A NO20052655A NO20052655D0 NO 20052655 D0 NO20052655 D0 NO 20052655D0 NO 20052655 A NO20052655 A NO 20052655A NO 20052655 A NO20052655 A NO 20052655A NO 20052655 D0 NO20052655 D0 NO 20052655D0
Authority
NO
Norway
Prior art keywords
merged
heterocyclic compounds
heterocyclic
compounds
merged heterocyclic
Prior art date
Application number
NO20052655A
Other languages
English (en)
Other versions
NO20052655L (no
Inventor
Juan C Jaen
Xiaoqi Chen
Pingchen Fan
Leping Li
Xi Chen
Jeffrey T Mihalic
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of NO20052655D0 publication Critical patent/NO20052655D0/no
Publication of NO20052655L publication Critical patent/NO20052655L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20052655A 2002-11-06 2005-06-02 Sammensmeltede heterocykliske forbindelser NO20052655L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42445602P 2002-11-06 2002-11-06
PCT/US2003/035543 WO2004043958A1 (en) 2002-11-06 2003-11-06 Fused heterocyclic compounds

Publications (2)

Publication Number Publication Date
NO20052655D0 true NO20052655D0 (no) 2005-06-02
NO20052655L NO20052655L (no) 2005-07-26

Family

ID=32312811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052655A NO20052655L (no) 2002-11-06 2005-06-02 Sammensmeltede heterocykliske forbindelser

Country Status (16)

Country Link
US (2) US7253179B2 (no)
EP (1) EP1562943A1 (no)
JP (1) JP4547266B2 (no)
KR (1) KR20050103184A (no)
CN (2) CN101134757A (no)
AU (1) AU2003285160B2 (no)
BR (1) BR0316070A (no)
CA (1) CA2505372A1 (no)
EA (1) EA009421B1 (no)
IS (1) IS7833A (no)
MX (1) MXPA05004739A (no)
NO (1) NO20052655L (no)
NZ (1) NZ540328A (no)
PL (1) PL376659A1 (no)
WO (1) WO2004043958A1 (no)
ZA (1) ZA200503654B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
MXPA05004739A (es) * 2002-11-06 2005-08-02 Tularik Inc Compuestos heterociclicos fusionados.
US7727998B2 (en) 2003-02-10 2010-06-01 Banyu Pharmaceutical Co., Ltd. Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
DE102010025663A1 (de) * 2010-06-30 2012-01-05 Karl-Heinz Glüsenkamp Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate
RU2013110324A (ru) 2010-08-10 2014-09-20 Эббви Инк. Новые модуляторы trpv3
US9012651B2 (en) 2011-03-24 2015-04-21 Abbvie Inc. TRPV3 modulators
US8772500B2 (en) 2011-10-24 2014-07-08 Abbvie Inc. TRPV3 modulators
CN106588812B (zh) * 2016-12-07 2019-02-22 烟台大学 一种酰氯制备2，4-二取代噻唑啉类化合物的方法
MY209594A (en) * 2019-01-14 2025-07-23 Zydus Lifesciences Ltd Novel substituted sulfonylurea derivatives
HUP2200222A1 (hu) 2022-06-17 2023-12-28 Richter Gedeon Nyrt MCHR1 antagonisták a Prader-Willi szindróma kezelésére

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US23085A (en) * 1859-03-01 chandler
US199549A (en) * 1878-01-22 Improvement in screw-propellers
US176694A (en) * 1876-04-25 Improvement in screw-cutting die-stocks
JPS5825980B2 (ja) 1976-02-12 1983-05-31 ヤマサ醤油株式会社 サイクリックヌクレオチドの定量法
EP0257701A1 (en) 1986-08-15 1988-03-02 Cedona Pharmaceuticals B.V. A process for preparing hydroxyl derivatives of compounds containing a carbazole, dibenzofurane or dibenzothiophene group
US5049655A (en) 1989-03-22 1991-09-17 The Salk Institute For Biological Studies Melanin-concentrating hormones
JP2906654B2 (ja) 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
JP3160941B2 (ja) 1991-06-17 2001-04-25 東レ株式会社 カルバゾール誘導体および免疫抑制剤
JP3253077B2 (ja) 1991-07-05 2002-02-04 スミスクライン・ビーチャム・ファーマシューティチ・ソシエタ・ペル・アチオニ ヒドロイソキノリン誘導体
CA2124455C (en) 1992-09-29 2004-09-14 Hiroshi Nagase Indole derivatives, process for producing the same and medicinal uses of the same
US5272146A (en) 1992-10-02 1993-12-21 The United States Of America As Represented By The United States Department Of Health And Human Services 1,2-dihydroellipticines with activity against CNS specific cancer cell lines
US5457208A (en) 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
US5464841A (en) 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
US5578725A (en) 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5849708A (en) 1995-06-06 1998-12-15 Joslin Diabetes Center, Inc. Promotion of eating behavior
EP0848060A3 (en) 1996-12-11 2000-02-02 Smithkline Beecham Corporation Novel human 11CB splice variant
AU739367B2 (en) 1997-01-16 2001-10-11 Toray Industries, Inc. Indolomorphinan derivative and agent for curing and preventing cerebral disorder
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1042498A4 (en) 1997-12-03 2003-05-07 Smithkline Beecham Corp METHOD FOR SEARCHING FOR AN AGONIST OR ANTAGONIST OF THE HUMAN 11 CB SPLICE VARIANT
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
WO2000015793A2 (en) 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Human gpcr proteins
GB9822158D0 (en) 1998-10-09 1998-12-02 Nycomed Imaging As Compositions
DE69935159T2 (de) 1998-12-28 2007-10-25 Takeda Pharmaceutical Co. Ltd. Screening-verfahren
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
WO2000049170A1 (en) 1999-02-18 2000-08-24 Smithkline Beecham Corporation MURINE 11cby RECEPTOR
EP1153932A1 (en) 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
EP1183539A1 (en) 1999-05-19 2002-03-06 AstraZeneca AB Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
WO2000075166A1 (en) 1999-06-08 2000-12-14 The Regents Of The University Of California Melanin concentrating hormone receptor
CA2378917A1 (en) 1999-07-14 2001-01-25 Merck & Co., Inc. Melanin-concentrating hormone receptor
WO2001007611A2 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
EP1196572A1 (en) 1999-07-27 2002-04-17 Smithkline Beecham Plc Axor21, a g-protein coupled receptor
AU7315800A (en) 1999-09-20 2001-04-24 Takeda Chemical Industries Ltd. Mch antagonists
CA2386474A1 (en) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
JP2003514549A (ja) 1999-11-16 2003-04-22 メルク エンド カムパニー インコーポレーテッド Ｇタンパク質共役受容体
JP2001226269A (ja) 2000-02-18 2001-08-21 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
CA2402147A1 (en) 2000-03-15 2001-09-20 Merck & Co., Inc. Melanin concentrating hormone receptor chimeric and fusion proteins
JP2005229804A (ja) 2000-03-24 2005-09-02 Astellas Pharma Inc 新規なメラニンコンセントレーティングホルモン受容体
CA2408913A1 (en) 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist
ATE489626T1 (de) 2000-07-05 2010-12-15 Takeda Pharmaceutical Verfahren zum screenen von mhc- rezeptorantagonisten oder -agonisten
WO2002002744A2 (en) 2000-07-05 2002-01-10 Synaptic Pharmaceutical Corporation Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
AU783403B2 (en) 2000-07-05 2005-10-20 H. Lundbeck A/S Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
AU2001279294A1 (en) * 2000-07-06 2002-01-21 Neurogen Corporation Melanin concentrating hormone receptor ligands
HUP0301382A2 (hu) 2000-10-20 2003-11-28 Pfizer Products Inc. Alfa-aril-etanol-amin-származékok és e vegyületeket tartalmazó béta-3 adrenergiás receptor agonista hatású gyógyászati készítmények
US20030022891A1 (en) 2000-12-01 2003-01-30 Anandan Palani MCH antagonists and their use in the treatment of obesity
IL155772A0 (en) 2000-12-22 2003-12-23 Schering Corp Piperidine mch antagonists and their use in the treatment of obesity
US6900329B2 (en) 2001-03-21 2005-05-31 Schering Corporation MCH antagonists and their use in the treatment of obesity
NZ527680A (en) 2001-03-21 2005-07-29 Pharmacopeia Drug Discovery Aryl and biaryl compounds having MCH modulatory activity
CA2443672C (en) * 2001-04-12 2011-03-29 Pharmacopeia, Inc. Aryl and biaryl piperidines used as mch antagonists
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
EP1392298B1 (en) 2001-05-04 2009-02-18 Amgen Inc. Fused heterocyclic compounds
EP1389189A2 (en) 2001-05-22 2004-02-18 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
MXPA04004956A (es) * 2001-11-26 2004-08-11 Schering Corp Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central.
JP2005532991A (ja) * 2002-01-10 2005-11-04 ニューロジェン・コーポレーション メラニン凝集ホルモン受容体リガンド：置換２−（４−ベンジル−ピペラジン−１−イルメチル）−及び２−（４−ベンジル−ジアゼパン−１−イルメチル）−１ｈ−ベンゾイミダゾールアナログ
MXPA05004739A (es) 2002-11-06 2005-08-02 Tularik Inc Compuestos heterociclicos fusionados.

Also Published As

Publication number Publication date
JP2006508130A (ja) 2006-03-09
US20080058365A1 (en) 2008-03-06
EA009421B1 (ru) 2007-12-28
CN1735613A (zh) 2006-02-15
JP4547266B2 (ja) 2010-09-22
EP1562943A1 (en) 2005-08-17
CN1330651C (zh) 2007-08-08
CA2505372A1 (en) 2004-05-27
US20040147538A1 (en) 2004-07-29
MXPA05004739A (es) 2005-08-02
AU2003285160A1 (en) 2004-06-03
NO20052655L (no) 2005-07-26
IS7833A (is) 2005-05-02
ZA200503654B (en) 2006-09-27
AU2003285160B2 (en) 2009-06-04
KR20050103184A (ko) 2005-10-27
US7253179B2 (en) 2007-08-07
WO2004043958A1 (en) 2004-05-27
EA200500770A1 (ru) 2005-12-29
PL376659A1 (pl) 2006-01-09
CN101134757A (zh) 2008-03-05
NZ540328A (en) 2008-02-29
BR0316070A (pt) 2005-09-27

Similar Documents

Publication Publication Date Title
IS8348A (is) Samrunnin heteróhringasambönd
IS7471A (is) Ný efnasambönd
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DK1551802T3 (da) Indol-3-svovlderivater
ATE467631T1 (de) Chinuclidinamidderivate
ATE368042T1 (de) Cephemverbindungen
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
DK1490355T3 (da) Indolylmaleimidderivater
IS7879A (is) Ný efnasambönd
IS7381A (is) Efnasambönd
DE602004019555D1 (de) Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
IS7414A (is) Oxó-azabísýklísk efnasambönd
NO20045659L (no) Forbindelser
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
IS7827A (is) Ný efnasambönd
ATE423771T1 (de) Tetrahydrochinolinderivate
DE602004007387D1 (de) 5-substituierte chinazolinonderivate
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
NO20052655D0 (no) Sammensmeltede heterocykliske forbindelser
NO20023047D0 (no) Kompenseringsanordning
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
ATE350379T1 (de) Substituierte benzdioxepine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application